A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance

Transboundary and Emerging Diseases

Volumn 62, Issue 4, 2015, Pages 367-387

  Barnett, P V ^a   Geale, D W ^b   Clarke, G ^c   Davis, J ^d   Kasari, T R ^e  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c Ministry of Agriculture and Forestry   (New Zealand)

^d Fisheries and Forestry   (Australia)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Emergency vaccination; FMD antigen banks; Foot and mouth disease; Higher potency vaccine; International trade; Surveillance

Indexed keywords

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; BOVINE; CATTLE DISEASES; DISEASE OUTBREAKS; FOOT AND MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; VACCINATION; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DISEASE OUTBREAKS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; VACCINATION; VIRAL VACCINES;

EID: 84934435221     PISSN: 18651674     EISSN: 18651682     Source Type: Journal    
DOI: 10.1111/tbed.12166     Document Type: Review

References (113)

1. Amareen, S., P. Grainger, L. Fleming, M. Mahapatra, H. Khalil, I. Bani Younis, A. Tahaineh, D. Paton, F. Aldomy, and S. Parida, 2008: Sero-surveillance against foot-and-mouth disease virus (FMDV) nonstructural protein antibodies in sheep, goats and cattle in Jordan after 2006 outbreak. Conference Proceedings from The Global Control of FMD - Tools, ideas and ideals, Erice, Italy, 14-17 October 2008., pp. 271-274.
2. Arnold, M. E., D. J. Paton, E. Ryan, S. J. Cox, and J. W. Wilesmith, 2008: Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination. Proc. R. Soc. B Biol. Sci. 275, 107-115.
3. Barnett, P. V., and H. Carabin, 2002: A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20, 1505-1514.
4. Barnett, P. V., and S. J. Cox, 1999: The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease. Vet. J. 158, 6-13.
5. Barnett, P. V., M. Forsyth, and S. Cox, 2000: Validating the efficacy of emergency foot-and-mouth disease vaccines in sheep following virus challenge using the non-structural polyprotein 3ABC MAT-ELISA. Animal Production and Health Div. Report. European Commission for the Control of foot-and-mouth Disease. Research Group of the Standing Technical Committee. Borovets (Bulgaria). 5-8 Sep 2000.
6. Barnett, P., A. J. M. Garland, R. P. Kitching, and C. G. Schermbrucker, 2002: Aspects of emergency vaccination against foot-and-mouth disease. Comp. Immunol. Microbiol. Infect. Dis. 25, 345-364.
7. Barnett, P. V., P. Keel, S. Reid, R. M. Armstrong, R. J. Statham, C. Voyce, N. Aggarwal, and S. J. Cox, 2004: Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the 'carrier' state in sheep. Vaccine 22, 1221-1232.
8. Bergevoet, R. H. M., M. A. P. M. van Asseldonk, M. H. Bokma-Bakker, N. Denormandie, A. R. W. Elbers, A. A. de Koeijer, P. Marchot, H. W. Saatkamp, N. Santini, and E. Wilkens, 2011: Feasibility study on the revision of Council Decision 2009/470/EC (ex 90/424/EEC) on expenditure in the veterinary field with a view to develop a harmonized EU framework for cost and responsibility sharing schemes for animal diseases. Final Report. doi: http://edepot.wur.nl/171897
9. Bergmann, I. E., V. Malirat, E. Neitzert, E. Beck, N. Panizzutti, C. Sánchez, and A. Falczuk, 2000: Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay. Arch. Virol. 145, 473-489.
10. Bergmann, I. E., V. Malirat, and E. Neitzert, 2005: Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination. Biologicals 33, 235-239.
11. Biswal, J. K., D. Paton, G. Taylor, and S. Parida, 2008: Detection of persistently foot-and-mouth disease infected cattle by salivary IGA test. Conference Proceedings from The Global Control of FMD - Tools, ideas and ideals, Erice, Italy, 14-17 October 2008, 377-382.
12. Brehm, K. E., N. Kumar, H. H. Thulke, and B. Haas, 2008: High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26, 1681-1687.
13. Brocchi, E., I. E. Bergmann, A. Dekker, D. J. Paton, D. J. Sammin, M. Greiner, S. Grazioli, F. De Simone, H. Yadin, B. Haas, N. Bulut, V. Malirat, E. Neitzert, N. Goris, S. Parida, K. Sørensen, and K. de Clercq, 2006: Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 24, 6966-6979.
14. Bronsvoort, B. M. D. C., K. J. Sørensen, J. Anderson, A. Corteyn, V. N. Tanya, R. P. Kitching, and K. L. Morgan, 2004: Comparison of two 3ABC enzyme-linked immunosorbent assays for diagnosis of multiple-serotype foot-and-mouth disease in a cattle population in an area of endemicity. J. Clin. Microbiol. 42, 2108-2114.
15. Cameron, A., 2012: A quantitative approach to determining waiting periods for FMD freedom Presentation at Open Sessions of the Standing Technical and Research Committees of the EUFMD Commission - Appliance of Science in the Progressive Control of FMD, 29-31 October 2012, Jerez de la Frontera, Spain. Available at http://www.fao.org/ag/againfo/commissions/eufmd/commissions/eufmd-home/reports/research-group/en/ (accessed September 5, 2013)
16. Cameron, A. R., and F. C. Baldock, 1998: A new probability formula for surveys to substantiate freedom from disease. Prev. Vet. Med. 34, 1-17.
17. Chen, S. P., T. M. Ellis, M. C. Lee, I. C. Cheng, P. C. Yang, Y. L. Lin, M. H. Jong, I. D. Robertson, and J. R. Edwards, 2007: Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan. Vet. Microbiol. 119, 164-172.
18. Chen, S. P., M. C. Lee, Y. F. Sun, and P. C. Yang, 2011: Application of non-structural protein ELISA kits in nationwide FMD surveillance in pigs to demonstrate virus circulation in Taiwan. Vet. Microbiol. 152, 266-269.
19. Chénard, G., P. Selman, and A. Dekker, 2008: Cedivac-FMD can be used according to a marker vaccine principle. Vet. Microbiol. 128, 65-71.
20. Clavijo, A., P. Wright, and P. Kitching, 2004: Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet. J. 167, 9-22.
21. Clavijo, A., K. Hole, M. Li, and B. Collignon, 2006: Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle. Vaccine 24, 1693-1704.
22. Cox, S. J., and P. V. Barnett, 2000: Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines, Appendix 31. FAO, Rome (Italy). Animal Production and Health Div. Report. European Commission for the Control of foot-and-mouth Disease. Research Group of the Standing Technical Committee. Borovets (Bulgaria). 5-8 Sep 2000. Rome (Italy)., pp. 247-254.
23. Cox, S. J., and P. V. Barnett, 2009: Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review. Vet. Res. 40, 13.
24. Cox, S. J., P. Dani, J. S. Salt, and P. V. Barnett, 1998: Effect of Emergency Vaccines on Local Virus replication and Virus Persistence in Sheep using Two Different Adjuvant Formulations, Appendix 17. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, United Kingdom (1998), pp. 139-143. FAO, Pirbright, UK.
25. Cox, S. J., P. V. Barnett, P. Dani, and J. S. Salt, 1999: Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 17, 1858-1868.
26. Cox, S. J., N. Aggarwal, R. J. Statham, and P. V. Barnett, 2003: Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21, 1336-1347.
27. Cox, S. J., C. Voyce, S. Parida, S. M. Reid, P. A. Hamblin, D. J. Paton, and P. V. Barnett, 2005: Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 23, 1106-1113.
28. Cox, S. J., C. Voyce, S. Parida, S. M. Reid, P. A. Hamblin, G. Hutchings, D. J. Paton, and P. V. Barnett, 2006: Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24, 3184-3190.
29. Cox, S. J., S. Parida, C. Voyce, S. M. Reid, P. A. Hamblin, G. Hutchings, D. J. Paton, and P. V. Barnett, 2007: Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge. Vaccine 25, 7687-7695.
30. Cox, S. J., B. V. Carr, S. Parida, P. A. Hamblin, H. Prentice, B. Charleston, D. J. Paton, and P. V. Barnett, 2010: Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve. Vaccine 28, 2318-2322.
31. Crowther, J. R., 2007: The Use of Non-structural Proteins of Foot and Mouth Disease Virus (FMDV) to Differentiate Between Vaccinated and Infected Animals. International Atomic Energy Agency. Available at: http://www-pub.iaea.org/MTCD/Publications/PDF/te_1546_web.pdf (accessed November 29 2011).
32. Davies, G., 2002: Foot and mouth disease. Res. Vet. Sci. 73, 195-199.
33. De Diego, M., E. Brocchi, D. Mackay, and F. De Simone, 1997: The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol. 142, 2021-2033.
34. Dekker, A., D. Sammin, M. Greiner, I. Bergmann, D. Paton, S. Grazioli, K. de Clercq, and E. Brocchi, 2008: Use of continuous results to compare ELISAs for the detection of antibodies to non-structural proteins of foot-and-mouth disease virus. Vaccine 26, 2723-2732.
35. Doel, T. R., 2003: FMD vaccines. Virus Res. 91, 81-99.
36. Doel, T. R., L. Williams, and P. V. Barnett, 1994: Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12, 592-600.
37. Donaldson, A. I., and R. P. Kitching, 1989: Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge. Res. Vet. Sci. 46, 9-14.
38. Engel, B., W. Buist, K. Orsel, A. Dekker, K. de Clercq, S. Grazioli, and H. van Roermund, 2008: A Bayesian evaluation of six diagnostic tests for foot-and-mouth disease for vaccinated and non-vaccinated cattle. Prev. Vet. Med. 86, 124-138.
39. European Union, 2003: EU Council Directive 2003/85/EC of 29 September 2003 on Community measures for the control of foot-and-Mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:306:0001:0087:EN:PDF (accessed Feb. 20, 2012).
40. Fowler, V. L., J. B. Bashiruddin, F. F. Maree, P. Mutowembwa, B. Bankowski, D. Gibson, S. Cox, N. Knowles, and P. V. Barnett, 2011: Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 29, 8405-8411.
41. Fu, Y., Y. Cao, P. Sun, H. Bao, X. Bai, P. Li, D. Li, Z. Lu, and Z. Liu, 2011: Development of a dot immunoblot method for differentiation of animals infected with foot-and-mouth disease virus from vaccinated animals using non-structural proteins expressed prokaryotically. J. Virol. Methods 171, 234-240.
42. Garland, A. J. M., and K. de Clercq, 2011: Cattle, sheep and pigs vaccinated against foot and mouth disease: does trade in these animals and their products present a risk of transmitting the disease?. OIE Rev. Sci. Tech 30, 189-206.
43. Geale, D. W., P. V. Barnett, G. W. Clarke, J. Davis, and T. R. Kasari, 2015: A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies II: waiting periods after emergency vaccination in FMD-free countries. Transboundary Emerg. Dis. 62, 388-406.
44. Georgiev, G. K., E. Veleva, L. Polihronova, and A. Rossi, 2004: Using NSP ELISA (Chekit-FMD-3ABC Bommeli-Intervet) as a Tool for FMDV Serosurveillance in Bulgaria. 2004. Session of the Research Group of the Standing Technical Committee of EuFMD, Chania, Crete, Greece, 11-15 October 2004. 446-561.
45. Goris, N., N. Praet, D. Sammin, H. Yadin, D. Paton, E. Brocchi, D. Berkvens, and K. de Clercq, 2007: Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field. Vaccine 25, 7177-7196.
46. Grubman, M. J., 2005: Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Biologicals 33, 227-234.
47. Grubman, M. J., and B. Baxt, 2004: Foot-and-mouth disease. Clin. Microbiol. Rev. 17, 465-493.
48. He, C., H. Wang, H. Wei, Y. Yan, T. Zhao, X. Hu, P. Luo, L. Wang, and Y. Yu, 2010: A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle. Vaccine 28, 3435-3439.
49. Hedger, R. S., 1970: Observations on the carrier state and related antibody titres during an outbreak of foot-and-mouth disease. J. Hyg. 68, 53-60.
50. Hema, M., S. B. Nagendrakumar, R. Yamini, D. Chandran, L. Rajendra, D. Thiagarajan, S. Parida, D. J. Paton, and V. A. Srinivasan, 2007: Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies. Vaccine 25, 4784-4794.
51. Hutber, A. M., R. P. Kitching, J. C. Fishwick, and J. Bires, 2011: Foot-and-mouth disease: the question of implementing vaccinal control during an epidemic. Vet. J. 188, 18-23.
52. IDEXX, 2013: Foot and Mouth Disease (FMD) (Livestock/Poultry Diagnostics). Available at: http://www.idexx.com/view/xhtml/en_us/livestock-poultry/ruminant/foot-and-mouth.jsf (accessed May 10, 2013).
53. Jamal, S. M., S. I. Shah, Q. Ali, A. Mehmood, M. Afzal, and A. Dekker, 2014: Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary. Transboundary Emerg. Dis. 61, 483-489.
54. Jaworski, J. P., D. Compaired, M. Trotta, M. Perez, K. Trono, and N. Fondevila, 2011: Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. J. Virol. Methods 178, 191-200.
55. King, A. M. Q., B. O. Underwood, D. McCahon, J. W. Newman, and F. Brown, 1981: Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature 293, 479-480.
56. Kitching, R. P., 2002: FMD Diagnostics: Requirements for Demonstration of Freedom from Infection. Technical item presented at the OIE Annual General Session, 2002. 70 SG/12/CS3 C
57. Kittelberger, R., G. F. Mackereth, M. Sewell, J. Keall, R. Clough, C. Pigott, and J. S. O'Keefe, 2008: Specificity of non-structural protein enzyme-linked immunosorbent assays for the detection of serum antibodies against foot-and-mouth disease virus in a target population in New Zealand. N. Z. Vet. J. 56, 227-232.
58. Kittelberger, R., T. Rawdon, A. McFadden, and R. Clough, 2011: Are we prepared for foot and mouth disease in cervidae? Vetscript 24, 21-25.
59. Ko, Y. J., H. Y. Jeoung, H. S. Lee, B. S. Chang, S. M. Hong, E. J. Heo, K. N. Lee, H. D. Joo, S. M. Kim, J. H. Park, and C. H. Kweon, 2009: A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1. J. Virol. Methods 159, 112-118.
60. Leforban, Y., and G. Gerbier, 2002: Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia. OIE Rev. Sci. Tech. 21, 477-492.
61. Lombard, M., P. P. Pastoret, and A. M. Moulin, 2007: A brief history of vaccines and vaccination. OIE Rev. Sci. Tech. 26, 29-48.
62. Lu, Z., X. Zhang, Y. Fu, Y. Cao, M. Tian, P. Sun, D. Li, Z. Liu, and Q. Xie, 2010: Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animals. J. Virol. Methods 170, 128-133.
63. Luyten, K., and K. de Clercq, 2007: FMD and CSF Coordination Action: Three workshops on the design and interpretation of post foot-and-mouth Disease vaccination serosurveillance by NSP tests: Workpackage 5, Diagnostics. EPIZONE, EUFMD (FAO) & EU COORDINATION ACTION FMD-CSF - Workpackage 5, Diagnosis, Tervuren, Belgium. http://www.fmd-and-csf-action.org/vaccine-banks-network/alignment-of-periods-for-recovery-of-free-status/workshops-on-the-design-and-interpretation-of-post-fmd-vaccination-serosurveillance-by-nsp-tests/D-WP5-2.pdf
64. Ma, L. N., J. Zhang, H. T. Chen, J. H. Zhou, Y. Z. Ding, and Y. S. Liu, 2011: An overview on ELISA techniques for FMD. Virol. J., 8, 419.
65. Mackay, D. K. J., M. A. Forsyth, P. R. Davies, and J. S. Salt, 1998: Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Vet. Q. 20, S9-S11.
66. Martin, P. A. J., A. R. Cameron, and M. Greiner, 2007: Demonstrating freedom from disease using multiple complex data sources. 1: a new methodology based on scenario trees. Prev. Vet. Med. 79, 71-97.
67. McVicar, J. W., and P. Sutmoller, 1976: Growth of foot and mouth disease virus in the upper respiratory tract of non immunized, vaccinated, and recovered cattle after intranasal inoculation. J. Hyg., 76, 467-481.
68. Moonen, P., L. Jacobs, A. Crienen, and A. Dekker, 2004: Detection of carriers of foot-and-mouth disease virus among vaccinated cattle. Vet. Microbiol. 103, 151-160.
69. Muroga, N., Y. Hayama, T. Yamamoto, A. Kurogi, T. Tsuda, and T. Tsutsui, 2012: The 2010 foot-and-mouth disease epidemic in Japan. J. Vet. Med. Sci. 74, 399-404.
70. Nagendrakumar, S. B., V. A. Srinivasan, M. Madhanmohan, S. Yuvaraj, S. Parida, A. Di Nardo, J. Horsington, and D. J. Paton, 2011: Evaluation of cross-protection between O 1 Manisa and O 1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O 1 Manisa antigen. Vaccine 29, 1906-1912.
71. Oh, Y., L. Fleming, B. Statham, P. Hamblin, P. Barnett, D. J. Paton, J. Park, Y. Joo, and S. Parida, 2012: Interferon- gamma induced by in vitro re-stimulation of CD4 + T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection. PLoS ONE 7, e44365.
72. OIE (World Organisation for Animal Health), 2003: Report of the meeting of the OIE Foot and Mouth Disease and Other Epizootics Commission, Paris, 12-14 February 2003 (71 SG/12/CS3 D). Paris, France. http://www.oie.int/doc/ged/D3081.PDF
73. OIE (World Organisation for Animal Health), 2004: Handbook on Import Risk Analysis for Animals and Animal Products. Volume 1: Introduction and Qualitative Risk Analysis. OIE (World Organisation for Animal Health), Paris, France.
74. OIE (World Organisation for Animal Health), 2005: Report of the Meeting of the OIE Scientific Commission for Animal Diseases, Paris, 14-19 January 2005 (73 SG/12/CS3 B). Paris, France. http://www.oie.int/fileadmin/Home/eng/Internationa_Standard_Setting/docs/pdf/SCAD/A_SCAD_Jan05.pdf
75. OIE (World Organisation for Animal Health), 2006a: Report of the Fourth Meeting of the OIE Ad hoc Group on Evaluation of Nonstructural Protein Tests for Foot-and-Mouth Disease Diagnosis, Paris, 23-25 January 2006. Paris, France. http://www.oie.int/doc/ged/D3330.PDF (accessed 14 December 2011)
76. OIE (World Organisation for Animal Health), 2006b: Report of the Meeting of the OIE Scientific Commission for Animal Diseases, Paris, 16-20 January 2006 (74 SG/12/CS3 B). Paris, France. http://www.oie.int/doc/ged/D2307.PDF
77. OIE (World Organisation for Animal Health), 2006c: Report of the Meeting of the Scientific Commission for Animal Diseases, Paris, 8-9 March 2006 (74 SG/12/CS3 C). Paris, France. http://www.oie.int/doc/ged/D2776.PDF (accessed Dec 14, 2011)
78. OIE (World Organisation for Animal Health), 2007: Report of the Ad hoc Group on Evaluation of Nonstructural Protein Tests for Foot and Mouth Disease Diagnosis. Paris, 22-23 January 2007 (75 SG/12/CS3 D). Paris, France. http://www.oie.int/doc/ged/D4351.PDF (accessed 14 Dec 2011)
79. OIE (World Organisation for Animal Health), 2011: Register of diagnostic tests certified by th OIE as validated as fit for purpose. Available at: http://www.oie.int/our-scientific-expertise/certification-of-diagnostic-tests/the-register-of-diagnostic-tests/ (accessed 12 December 2011).
80. OIE (World Organisation for Animal Health), 2012a: Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees), Chapter 2.1.5 Foot and Mouth Disease. 7th edn., pp. 1-29. OIE (World Organisation for Animal Health). www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.05_FMD.pdf (accessed 23 Nov 2012)
81. OIE (World Organisation for Animal Health), 2012b: Terrestrial Animal Health Code (2012), Volume 2, Chapter 8.5 Foot and Mouth Disease. 21 edn. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahc/2010/en_chapitre_1.8.5.htm (accessed 20 November 2012).
82. OIE (World Organisation for Animal Health), 2013: List of FMD free members: According to RESOLUTION No. 14 (80 th General Session May 2012) Available at: http://www.oie.int/animal-health-in-the-world/official-disease-status/fmd/list-of-fmd-free-members/ (accessed 11 August 2013).
83. Orsel, K., 2007: Foot and Mouth Disease Virus in Different Host Species; the Effect of Vaccination on Transmission. Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands. doi: 1874/139459
84. Orsel, K., and A. Bouma, 2009: The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field. Can. Vet. J. 50, 1059-1063.
85. Parida, S., 2009: Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev. Vaccines 8, 347-365.
86. Parida, S., S. J. Cox, S. M. Reid, P. Hamblin, P. V. Barnett, T. Inoue, J. Anderson, and D. J. Paton, 2005: The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease. Vaccine 23, 5186-5195.
87. Parida, S., J. Anderson, S. J. Cox, P. V. Barnett, and D. J. Paton, 2006a: Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 24, 1107-1116.
88. Parida, S., Y. Oh, S. M. Reid, S. J. Cox, R. J. Statham, M. Mahapatra, J. Anderson, P. V. Barnett, B. Charleston, and D. J. Paton, 2006b: Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 24, 964-969.
89. Parida, S., L. Fleming, Y. Oh, M. Mahapatra, P. Hamblin, J. Gloster, C. Doel, S. Gubbins, and D. J. Paton, 2007a: Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. Vaccine 25, 7806-7817.
90. Parida, S., L. Fleming, D. Gibson, P. A. Hamblin, S. Grazioli, E. Brocchi, and D. J. Paton, 2007b: Bovine serum panel for evaluating foot-and-mouth disease virus nonstructural protein antibody tests. J. Vet. Diagn. Invest. 19, 539-544.
91. Park, J. H., J. Y. Park, Y. J. Kim, J. K. Oem, K. N. Lee, S. J. Kye, and Y. S. Joo, 2004: Vaccination as a control measure during the outbreak of Foot-and-Mouth disease in 2000 in Korea. In: Schudel, A. S., Lombard, M. L. (eds), Karger, Basel. Control of infectious animal diseases by vaccination. Dev. Biol. 119, 63-70.
92. Paton, D. J., K. de Clercq, M. Greiner, A. Dekker, E. Brocchi, I. Bergmann, D. J. Sammin, S. Gubbins, and S. Parida, 2006a: Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24, 6503-6512.
93. Paton, D., D. Sammin, K. C. Dyrting, M. Chow, L. Fleming, B. Verin, N. Ferris, G. McDonagh, J. O'Connor, P. Hamblin, D. Gibson, and S. Parida, 2006b: Comparative evaluation of serological tests for the detection of foot-and-Mouth disease virus infection in vaccinated pigs. Appendix 51, 2006 Session of the Research Group of the Standing Technical Committee of EuFMD. Food and Agriculture Organization of the United Nations, Paphos, Cyprus. http://www.fao.org/ag/againfo/commissions/docs/research_group/paphos/Paphos_FinalRep.pdf (accessed 3 December, 2012).
94. Paton, D. J., K. J. Sumption, and B. Charleston, 2009: Options for control of foot-and-mouth disease: knowledge, capability and policy. Philos. Trans. R. Soc. B 364, 2657-2667.
95. Paton, D. J., M. Sinclair, and R. Rodríguez, 2011: Qualitative risk assessment of the spread of foot and mouth disease by international trade in deboned beef. OIE Tech. Ser., 11, 1-105.
96. Perkins, J., S. Parida, and A. Clavijo, 2007: Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease. Clin. Vaccine Immunol. 14, 1472-1482.
97. Persson, K., A. Nordengrahn, C. Decker, and M. Merza, 2004: The development of an indirect ELISA for the detection of antibodies to the non-structural protein 3ABC of the foot and mouth disease virus; the use of a polyclonal conjugate that allows a multi-species detection of antibodies. Poster. 2004 Session of the Research Group of the Standing Technical Committee of EuFMD. Chania, Crete, Greece.
98. Pluimers, F. H., 2005: Foot-and-mouth disease control using vaccination: the Dutch experience in 2001. In: Schudel, A., Lombard, M. (eds), Karger, Basel. Control of Infectious Animal Diseases by vaccination. Dev. Biol. 2004, vol 119, pp 41-49.
99. Rweyemamu, M. M., L. Black, A. Boge, A. C. Thorne, and G. M. Terry, 1984: The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle. J. Biol. Stand., 12, 111-120.
100. Salt, J. S., L. Williams, R. Statham, and P. V. Barnett, 1995: Further Studies on the Rate of Development of Protection in Cattle Given Emergency Vaccination Against FMD. Appendix 17. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Modelling (1995), pp. 90-97. FAO.
101. Salt, J. S., P. V. Barnett, P. Dani, and L. Williams, 1998: Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 16, 746-754.
102. Sánchez-Aparicio, M. T., M. F. Rosas, R. M. Ferraz, L. Delgui, J. J. Veloso, E. Blanco, A. Villaverde, and F. Sobrino, 2009: Discriminating foot-and-mouth disease virus-infected and vaccinated animals by use of β-galactosidase allosteric biosensors. Clin. Vaccine Immunol. 16, 1228-1235.
103. Schley, D., D. J. Paton, S. J. Cox, S. Parida, and S. Gubbins, 2009: The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks. Epidemiol. Infect. 137, 1494-1504.
104. Sellers, R. F., K. A. J. Herniman, and I. D. Gumm, 1977: The airborne dispersal of foot and mouth disease virus from vaccinated and recovered pigs, cattle and sheep after exposure to infection. Res. Vet. Sci. 23, 70-75.
105. Sergeant, E. S. G., 2013: EpiTools epidemiological calculators. AusVet Animal Health Services and Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease. Available at: http://epitools.ausvet.com.au/content.php?page=home (accessed 30 November 2012).
106. Shen, F., P. D. Chen, A. M. Walfield, J. Ye, J. House, F. Brown, and C. Y. Wang, 1999: Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine 17, 3039-3049.
107. Srinivasan, V. A., S. B. Nagendrakumar, M. Madhanmohan, V. Maroudam, P. Santhakumar, S. Parida, J. Horsington, and D. Paton, 2006: Preliminary results to evaluate cross-protection between 01 Manisa and 01 Campos in Cattle. Appendix 30. 2006 Session of the Research Group of the Standing Technical Committee of EuFMD. Food and Agriculture Organization of the United Nations, Paphos, Cyprus. (accessed 3 December, 2012).
108. Sutmoller, P., and R. Casas Olascoaga, 2002: Unapparent foot and mouth disease infection (sub-clinical infections and carriers): implications for control. OIE Rev. Sci. Tech. 21, 519-529.
109. Svanova, S., 2013: IAEA standard FMDV sera: Positive Control Sera for diagnosing Foot-and-Mouth-Disease (FMDV) Available at: www.svanova.com/showpage.asp?pageID=15&productID=174 (accessed 29 November, 2011).
110. United States Department of Agriculture. Animal and Plant Health Inspection Service - Veterinary Services, 2011: Evaluation: Foot and Mouth Disease in Japan. Available at: https://web01.aphis.usda.gov/db/mtaddr.nsf/2f5c87c0140172cb852564bf0046d1e2/c1057134f0c3dab385256bb0004ffcda/$FILE/JapFMD.1.pdf (accessed 1 March, 2012).
111. United States Department of Agriculture. Animal and Plant Health Inspection Service. Veterinary Services, 2011: Appendix A: Vaccination for foot-and-mouth disease: FAD PReP - Foreign Animal Disease Preparedness & Response Plan. National Animal Health Emergency Management System (NAHEMS) Guidelines: Vaccination for Contagious Diseases, p. 52. https://fadprep.lmi.org/NAHEMS/NAHEMS%20%202010%20and%20beyond/FADPReP_NAHEMS_AppA%20_VaxFMD_FINAL_20April2011v2.pdf.
112. Uttenthal, A., S. Parida, T. B. Rasmussen, D. J. Paton, B. Haas, and W. G. Dundon, 2010: Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev. Vaccines 9, 73-87.
113. Vosloo, W. J., J. Morris, and N. Singanallur, 2012: Testing the efficacy of O1 Manisa High Potency Vaccine Against Challenge with O/Vietnam/2010 (O Mya98 Topotype) in Pigs. Presentation made at the Open Session of the EuFMD, Appliance of Science in the Progressive Control of FMD, 29-31 October 2012, Jerez de la Frontera, Spain. Available at http://www.fao.org/ag/againfo/commissions/eufmd/commissions/eufmd-home/reports/research-group/en/, (accessed September 5, 2013).